Omnichannel approach improved atorvastatin prescribing in dyslipidemia, suggesting effective engagement strategies.
Statins remain the cornerstone of lipid-lowering therapy for cardiovascular risk prevention. Despite strong guideline support, therapeutic inertia and brand competition pose challenges in consistent statin utilization. This article presents a six-month omnichannel digital campaign executed by Hidoc Dr. across Tamil Nadu, India, aimed at re-establishing physician engagement with atorvastatin therapy in dyslipidemia and stroke prevention. The campaign targeted over 36,000 physicians, generating more than 2.1 million impressions and over 94,000 clicks. With a strong CTR of 5%, the campaign demonstrated the power of structured digital education to reinforce evidence-based practices and guideline-aligned prescribing behavior.
No takes yet. Share an insight, caveat, or question.
Shaikh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: